{"name":"Danish Headache Center","slug":"danish-headache-center","ticker":"","exchange":"","domain":"","description":"The Danish Headache Center (DHC) is an academic medical center at Rigshospitalet in Copenhagen, Denmark. It was founded in 2001 and currently employs more than 100 health care professionals, scientists and administrative staff. The DHC focuses on health care services, education, and research related to headache disorders and facial pains.","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Amylin","genericName":"Amylin","slug":"amylin","indication":"Other","status":"phase_1"},{"name":"Calcitonin Gene-Related Peptide","genericName":"Calcitonin Gene-Related Peptide","slug":"calcitonin-gene-related-peptide","indication":"Other","status":"marketed"},{"name":"Imigran","genericName":"Imigran","slug":"imigran","indication":"Other","status":"phase_1"},{"name":"Maxipost","genericName":"Maxipost","slug":"maxipost","indication":"Other","status":"phase_1"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"VIP","genericName":"VIP","slug":"vip","indication":"Migraine","status":"marketed"}]}],"pipeline":[{"name":"Amylin","genericName":"Amylin","slug":"amylin","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"VIP","genericName":"VIP","slug":"vip","phase":"marketed","mechanism":"VIP (Vasoactive Intestinal Peptide) is a neuropeptide that acts as a vasodilator and neuromodulator to reduce migraine and headache symptoms.","indications":["Migraine","Cluster headache","Tension-type headache"],"catalyst":""},{"name":"Calcitonin Gene-Related Peptide","genericName":"Calcitonin Gene-Related Peptide","slug":"calcitonin-gene-related-peptide","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Imigran","genericName":"Imigran","slug":"imigran","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Maxipost","genericName":"Maxipost","slug":"maxipost","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNTXBMc3h6VUpkWmhyNUtsclk3MlBGdmViV21XRTdhMTZKbmE4ay1iTnRyaFBoNFowUnJZVlcwZkMxbUlUUjRmMjlrT2JqdS0xV0JEOVFWMkJocGt0WmNyQjd4dTM5MVJXZjhoTXFNaER0YlVsTzBKaGczVExWTUp0bENlRGw0SlY3SHBlQlNtMEhOSmhhV3RYNlNuNFp0bXpRdmZfWkRyTk1EMGlO?oc=5","date":"2026-02-13","type":"pipeline","source":"The Pharma Letter","summary":"More positive signs for Lundbeck’s mid-stage migraine candidate - The Pharma Letter","headline":"More positive signs for Lundbeck’s mid-stage migraine candidate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNVlp2YnVnQ19HNzM5Qkd5U0xKeng5UzBZUHhUYkk0a3Z2MzV1UmFTOHRPbmhlaExpNEJWbGZaNDVhVk5tcnJxaTktMmgydDF5MDA0NE1lc2JDZDBndVVIT3VqNE9aUDRELTEtSi0tUnpPNGFqbUVpV0VXZExocEhpemExRWNsd3c0UGtwTmdONmxZQ2gzWHFmWnZySTF6RkN5YW9Namo5VG5Ja1lZamwxYXBB?oc=5","date":"2025-06-25","type":"pipeline","source":"Pharmaceutical Executive","summary":"Teva’s Ajovy Maintains Long-Term Effectiveness in Preventing Chronic, Episodic Migraine - Pharmaceutical Executive","headline":"Teva’s Ajovy Maintains Long-Term Effectiveness in Preventing Chronic, Episodic Migraine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPa21vakJ5Y0lNZTFodFZsc0pmbENITnd3eWpnd0R4emJkencwMTNGMVFTWXdsWExXZzQ1VTFSTy1lY1pfUXRaSGU1cG9LdFhjYTI2V28tZ1pXVGgxcFpxRjdkODgweHgxZV8wRG9Yc0UyZ0cxUzR0a1RXSFVCLXdmYTV3TDVlcjNsTTh1ei1JVE5YNWhIeWxPTQ?oc=5","date":"2025-05-16","type":"pipeline","source":"Biostock","summary":"Saniona-backed Cephagenix secures EUR 9 million in seed financing - Biostock","headline":"Saniona-backed Cephagenix secures EUR 9 million in seed financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9wZHMtRjVtWENrcjRackFrWHlDem42ZUY1TzFLUXdpNzR0V0ZhX19rU3RoOWV1UkZLeEdPeVk4MGVFNHM4ODdhQWdHbUNYSUlidEJ6ZWF6U05vaFdpODZn?oc=5","date":"2024-11-03","type":"pipeline","source":"nature.com","summary":"The search for non-evoked markers of pain in the GTN mouse model of migraine - nature.com","headline":"The search for non-evoked markers of pain in the GTN mouse model of migraine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxObTZuWkdDZmMxanhhTnhSWWtQZldjVTBzaWM0M3VaVHdmX25qUW1WaFZid3c1dWtGNTd4QTNrd0lzdkxLb01KVDJGajhnSWN4OUs5dklwWXhtcHJTNC15NXlLOG9ST2M3SWg2ZUNYd0dlcGc5T0FZQlozNG1Jb3VsamNEZFBaQ3UwcXVHUUprdDJGeXNyemVXTkJfZDczMUd3Q0g2SndwbnhKcE8zTVRuNnBuOFJmODVNeklRS09pY1ZCVWpLXzdmeENn?oc=5","date":"2024-06-17","type":"pipeline","source":"Reuters","summary":"Explainer: What other health conditions might weight-loss drugs treat? - Reuters","headline":"Explainer: What other health conditions might weight-loss drugs treat?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5ySEszWWxPcDRYdVFuVXJkcjZ3ckxIOTZNTTRyZW5jelIwdjRqV3lSUUlldHJNSU1KNW5mWUh1dXB1amFPbnk1VWN1d3JmYUp6VEFONUhCYXIwVFc4QXNpV1UwbXUzOXdVeHc?oc=5","date":"2023-12-10","type":"pipeline","source":"Neurology® Journals","summary":"Chronobiology differs between men and women with cluster headache, clinical phenotype does not - Neurology® Journals","headline":"Chronobiology differs between men and women with cluster headache, clinical phenotype does not - Neurology® Journals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQdG9nTEN1VmhySjlEU2NXTEpUZHdZekE1VXR5U1l4SWh0MkVBRkNjaU4ySnpQaGRZS1NOOHdiWmhlUnQzeTBQdlhpbmxkZlhiOXVrM2laT05IbGJxVEFMdHBsVWZaTk94TU4zU2VBdVhVeXVBWFFaNVNYMGdtRGFRb1g2TDhyb3V5VmVyRDEta3RMNWNEdHc?oc=5","date":"2023-10-09","type":"pipeline","source":"Frontiers","summary":"Medication-overuse headache—a review of different treatment strategies - Frontiers","headline":"Medication-overuse headache—a review of different treatment strategies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9zU1d0Y09zZmptcDBKalRwUEdHVmUtb2c1Mk5XRUVFNUlMaXJxNVBUSHdUeTB5TVFic0I2bHFXa3VOYlAwTDFfUm5VTlFoSkpVNFJtTmZ3R19neHBENjI4?oc=5","date":"2023-07-31","type":"pipeline","source":"nature.com","summary":"Multi-omic analyses of triptan-treated migraine attacks gives insight into molecular mechanisms | Scientific Reports - nature.com","headline":"Multi-omic analyses of triptan-treated migraine attacks gives insight into molecular mechanisms | Scientific Reports","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNb2lwME1kcUIxRlB4dEhweVdKbWZORG9ualdMbmJHN2VOcjd3R2VlS0xfQXNaRFo5c29lc0NpMHNqTnp4VExGdFNUMnJxbDRRakN4eExMai12dWNYalA5OFhBSEpxTVp0SHF1c1dkNG83R0pLR3p4Umdoek5ScjJpT0s1cXdqaWRib3pPN3N1aV9qX29tY1BxN0xWSV9VTkozRFE?oc=5","date":"2023-06-28","type":"pipeline","source":"Frontiers","summary":"The ATP sensitive potassium channel (KATP) is a novel target for migraine drug development - Frontiers","headline":"The ATP sensitive potassium channel (KATP) is a novel target for migraine drug development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPcWYtS0JrbjQxd29xNU52ejhoVHc1Q093akdYdi12T2hjVnR1ZzZILXpWdXNKTjk2YTl2WU5xSjBvX3R0RVNoWHpOU1IxRl8yU0lOQ2Ewak5FR2hhZ05TY3pvaXpXaVU4c01BSVY4RFJRdmM4TEw3VVkxcDlpcTQzNm0ya0wyUFVSZzduY1N1NnB2Zw?oc=5","date":"2023-01-26","type":"pipeline","source":"Biostock","summary":"Saniona and Cephagenix on the joint migraine project - Biostock","headline":"Saniona and Cephagenix on the joint migraine project","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQSW5tVXZLX1p5dm80b1p5alRmd2ppbmE5Y2JLVk9ZUzRwazM2YllfbTRCYi1CbHZFVzJNMjFEQ1lwUU54djhwOFIyeGtJR0pDOXFTbTZpUDVxUW5xUnRxQzg2OE1pZTlPd3JFaEkyRTl3WHgzRnBFX052Q0xKcERBR3dFNDNma1U?oc=5","date":"2020-02-18","type":"pipeline","source":"BioSpace","summary":"Saniona Co-Founds New Migraine-Focused Company - BioSpace","headline":"Saniona Co-Founds New Migraine-Focused Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOdTBaLUZUMklIMVlWekt2b3JyVHJ3SGpWQXhZNkZibC02WFBqOXFIV0NUNjZJdEpBTnJjV3VpbGZ4eXdSNnJyeXpoY1JLWWRFNkx4enNYTF8tSnlnTDA3VXZKSkxYVGtXa29JNG00d3hHMmM5NzhkRWFCSlp5Yy1jRTJzemV1ZVNqZ09wUWFFUDBGWjdteHNaQnBpS2QtcUpnWWNrODlleHZ4TnY1M2c?oc=5","date":"2018-02-13","type":"pipeline","source":"ScienceNordic","summary":"Ibuprofen can damage men’s endocrine system - ScienceNordic","headline":"Ibuprofen can damage men’s endocrine system","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"phase_1":3,"marketed":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}